New in vitro model evaluating antiseptics' efficacy in biofilmassociated Staphylococcus aureus prosthetic vascular graft infection community in the extracellular polymeric substance that adheres to living or inanimate surfaces [9] . Owing to their resistance to antibiotics and antiphagocytic effects, biofilms can frequently cause persistent chronic infections that are difficult to treat. Biofilms are significant causes of morbidity and mortality [10, 11] . Due to the high rates of mortality and morbidity associated with biofilms, several studies have been conducted on antimicrobials and particularly on the effectiveness of antibiotics against biofilms. It has been demonstrated that antibiotics show limited efficacy against biofilms as the biofilm layer persists. Hence, it should be borne in mind that disinfectants serve as a significant alternative against human mucosa and biofilms on the surfaces of medical devices [12] . Biofilm development on the vascular prosthesis plays a significant role in the difficulties encountered when treating PVGI [13, 14] . Moreover, there is a lack of representative in vitro models that enable us to study interactions of biofilms and antiseptics on infected vascular grafts under wound environment simulating conditions. The aims of the current study were to develop a new in vitro model of PVGI and to evaluate both antimicrobial and biofilm-disrupting efficacy of 0.1% octenidine dihydrochloride, 10% povidone-iodine and 0.02% chlorhexidine digluconate solutions against biofilmproducing S. aureus.
Methods
All of the following in vitro experiments were performed during June-July 2017 in Vilnius, Lithuania. The experiments were performed at least in triplicate. Sterile phosphate buffer solution (PBS) served as a negative control.
Methods for biofilm detection Qualitative selection of biofilm-producing S. aureus isolates
Qualitative biofilm production of the laboratory collection of clinical S. aureus isolates was evaluated as documented in previous studies [15, 16] . Six strains of S. aureus, which were isolated from unrelated clinical cases, were cultured overnight on tryptic-soy agar (Tryptic-soy agar (TSA), Liofilchem, Italy). After the cultivation, one isolated colony from each strain was transferred to Congo red agar (brain heart infusion broth 37 g l −1 , sucrose 50 g l −1 , agar 10 g l −1 and Congo red indicator 8 g l −1 ) and incubated at 37 °C overnight. S. aureus strains, which produced black colonies on Congo red agar, were considered biofilm-producing strains [15, 17] .
Quantitative selection of biofilm-producing S. aureus isolates S. aureus biofilm production was quantified spectrophotometrically, using a modified crystal violet biofilm assay [18] . Briefly, the six strains of S. aureus were cultured at 37 °C overnight in tryptic-soy broth (tryptic-soy broth (TSB), Liofilchem, Italy) in a shaker at 180 Revolutions per minute. After the incubation, twofold dilution was performed with fresh TSB and cultured until Optical density (OD) 600 nm reached 0.5 Colony forming units (c.f.u.) ml −1 . Also, 100 µl of each culture were transferred to 96-well microplates, cultured at 37 °C under stationary conditions for 24 h and the wells were washed three times with 100 µl −1 PBS (pH 7.2). Biofilms were fixed with buffered formaldehyde (pH 7.4) for 1 h, then washed and stained with 0.1% aqueous crystal violet. The absorbance of solubilized crystal violet was determined at A 600 nm in an ELISA reader (Dynex MRX) and extracted with 30% acetic acid.
Microscopic evaluation of the integrity of S. aureus biofilms
Biofilm-producing S. aureus strain was cultured in TSB overnight and grown on 22×22 mm borosilicate glass coverslips. Briefly, 100 µl of the overnight culture of S. aureus (1.49×10 6 c.f.u. ml −1 ) was transferred to four (one for each antiseptic group) sterile 90 mm diameter Petri dishes, containing six coverslips each and 10 ml of TSB, supplemented with 1% of type B gelatine (Sigma). The coverslips were incubated at 37 °C under stationary conditions for 48 h, then were aspirated and washed three times, each time using 10 ml of sterile PBS (pH 7.2). Coverslips were transferred to six-well tissue culture plates (Nunc) and 1.5 ml of 37 °C pre-warmed 0.1% octenidine dihydrochloride (Octenisept, Schulke and Mayr GmbH, Germany), 10% povidone-iodine (Betadine, EGIS Pharmaceuticals LTD, Hungary) and 0.02% chlorhexidine digluconate (Fresenius Kabi AG, Germany) solutions were applied for 10 min. The integrity of S. aureus biofilms was visualized by staining the coverslips with 0.5% crystal violet, after washing and fixing biofilms with 5 ml of 10% buffered formaldehyde (pH 7.4). The coverslips were dried at room temperature and visualized using light microscopy. The glass coverslips were scanned with a Scan Scope XT Slide Scanner (Leica Aperio Technologies, Vista, CA, USA). The percentage of biofilm covered area on the slides was analysed with the Halo Area Quantification v1.0 algorithm.
Testing antimicrobial activity of antiseptics against biofilm in the LCWPB model
Testing the antimicrobial activity of different antiseptics to evaluate the efficacy against S. aureus biofilms was done using the Lubbock chronic wound pathogenic biofilm (LCWPB) model [19] . Twenty-four of the well tissue culture plates (Nunc) were filled with 500 µl of modified Lubbock media (50% of sheep blood plasma, 5% of cold lysed horse erythrocytes, 45% of brain-heart infusion and 1% of type B gelatine). Each well was inoculated with 5 µl of an overnight culture of S. aureus to reach the final concentration of 8.18×10 7 c.f.u. ml ) were enumerated by serial dilutions and plating on mannitol-salt agar (Liofilchem, Italy).
Testing antimicrobial activity of antiseptics against biofilm in a new PVGI model
The LCWPB model [19] was modified, optimized and used as a basis for the development of the in vitro PVGI model, caused by a previously selected strong biofilm-producer. A sterile non-impregnated woven 6 mm diameter Dacron graft (Twillweave, Vascutek Terumo) was cut into even pieces (9.4 mm x 6 mm). The pieces of the vascular graft were immersed into 20 ml of modified Lubbock media, which was inoculated with 200 µl of the overnight S. aureus culture to reach approximately 1.49×10 6 c.f.u. ml −1 . In this medium, the vascular grafts were incubated at 37 °C under stationary conditions for 48 h. The biofilm-coated vascular grafts were then removed and gently washed with 10 ml of sterile PBS (pH 7.2), then transferred to 24-well plates (one piece of vascular graft per well) and 1.5 ml of 37 °C pre-warmed 0.1% octenidine dihydrochloride, 10% povidone-iodine, 0.02% chlorhexidine digluconate solution and PBS were added to the wells (six wells for one antiseptic group) and incubated at 37 °C for 10 min. After the incubation, the antiseptics were aspirated and the vascular grafts were washed three times with 3 ml of sterile PBS (pH 7.2), then 1.5 ml of Lubbock's medium was added to each well and the plates were again incubated in a thermostat for 24 h at 37 °C. Then the medium was aspirated from the wells and grafts were washed three times with 3 ml of PBS. The washed vascular grafts were transferred to sterile test tubes and homogenized in 1 ml of PBS (pH 7.2) in a shaker at 500 r.p.m. for 20 min. The total number of viable biofilmassociated bacteria (c.f.u. g −1 ), harvested from the grafts, were enumerated by serial dilution and plating on mannitol-salt agar (Liofilchem, Italy).
Scanning electron microscopy of prosthetic vascular grafts
The surface of a woven Dacron vascular graft (Twillweave, Vascutek Terumo) and colonization of it with S. aureus biofilms were visualized using a scanning electron microscope (SEM, HITACHI TM-1000, Japan) at an accelerating voltage of 15 kV. The vascular grafts colonized with biofilms, removed from the newly developed PVGI model, were washed with PBS (pH 7.2) and fixed with 5% glutaraldehyde for 12 h. After the fixation, the grafts were washed, dehydrated using series of ethylalcohol and coated with a thin layer of gold prior to scanning. Ten images per sample were taken to obtain a representative view of the graft with and without a biofilm.
Statistical analysis
Differences in biofilm mass and c.f.u. ml −1 between the groups were calculated using the Kruskal-Wallis and Mann-Whitney U-test for continuous variables with skewed distribution used for independent variables. Wilcoxon test was used for two dependent variables. Statistical significance was set at P<0.05. Data were analysed using SPSS version 20 (IBM, New York, USA).
RESuLTS

Characteristics of the biofilm production in clinical S. aureus isolates
All the tested strains were isolated from clinically unrelated infection cases in Vilnius, Lithuania between June-July 2017. Five out of six S. aureus isolates, tested for biofilm production, produced black colonies on Congo red agar (data not shown), therefore, they became considered biofilm-producers.
Further quantification of S. aureus biofilm production in vitro was assessed by using a spectrophotometric crystal violet absorption assay. The six strains of S. aureus exhibited different rates of biofilm production. The rate of biofilm production was low for one of the six strains, moderate for four strains and strong for one strain. The strain that showed signs as a strong biofilm-producer was used for further experiments.
Antiseptic effect on microscopic integrity against S. aureus biofilms S. aureus biofilms successfully formed on the surface of glass coverslips and on average covered 73% of the glass area (Figs 1 and 2) . Surprisingly, strong biofilm-disrupting activity was observed after applying 0.02% chlorhexidine digluconate solution; the mean value of the coverslip surface covered with S. aureus biofilms decreased from 73.75 to 10.55% (P=0.002). The lowest activity was observed with 0.1% octenidine dihydrochloride [73.75 to 69.75% (P=0.065)], and a slightly stronger activity was detected with 10% povidone-iodine (from 73.75 to 64.75%, P=0.065), (Fig. 1) .
Scanned pictures of glass coverslips with biofilm remains are shown in Fig. 2 (one representative scanned image for each group; control group, octenidine dihydrochloride, chlorhexidine digluconate and povidone-iodine). On visual evaluation; octenidine dihydrochloride and povidone-iodine destroyed the biofilm only partially, without significant association between the groups as well as with the control group, however, the treated glass coverslips with chlorhexidine digluconate show completely destroyed S. aureus biofilm (P=0.002) (Fig. 1) . ). No viable S. aureus was recovered after biofilms' exposition to 0.1% octenidine dihydrochloride and 10% povidoneiodine (Fig. 3) .
Antimicrobial activity of antiseptics against S. aureus biofilms in a new PVGI model
The LCWPB model was chosen as a base for a PVGI model, due to the good resemblance of the biofilm structures that form in the wound environment in vivo. After the demanded time of incubation, the graft (Fig. 4a) was successfully colonized with biofilms (Fig. 4b) , as seen in SEM photography (Fig. 4) . After 48 h of incubation in the LCWPB model, the pieces of vascular graft on average were colonized with 3.89×10 17 c.f.u. g −1 of S. aureus. All the tested antiseptics demonstrated antimicrobial activity against S. aureus biofilms, formed on the vascular grafts in the newly developed PVGI model (P=0.002). After administering antiseptics, the number of viable S. aureus (c.f.u. g ) decreased by seven orders of magnitude on the vascular graft. Octenidine dihydrochloride demonstrated the best antimicrobial effect against S. aureus biofilms, grown on vascular grafts, although the overall effect did not considerably differ from the other tested antiseptics under the experimental conditions. However, 0.1% octenidine dihydrochloride exhibited a statistically significant antimicrobial effect, compared to 10% povidone-iodine (P=0.009) and 0.02% chlorhexidine digluconate solution (P=0.041) (Fig. 5) .
dISCuSSIon
Three commonly used antiseptic solutions -0.02% chlorhexidine digluconate, 10% povidone-iodine and 0.1% octenidine dihydrochloride were used in our study to evaluate their effect on S. aureus biofilms, present on the surfaces of woven Dacron vascular grafts. In our study, the LCWPB model was successfully adapted as a base of the PVGI model to simulate wound conditions when biofilms form on the prosthetic vascular grafts. The tested antiseptics exhibited statistically significant antimicrobial effects against biofilms, formed on the grafts using a newly developed PVGI model. Our findings support the hypothesis, that the structure of a vascular graft might be responsible for profound persistence of bacteria on the graft and increased biofilms' resistance to the antiseptics. We found that the antimicrobial efficacy of the antiseptics decreased dramatically, when the tested antiseptics were applied to the biofilms on the vascular grafts, colonized with S. aureus biofilms rather than grown on the glass coverslips and in the modified LCWPB model without the presence of the graft. This could be explained by the fact, that the presence of a woven vascular graft in the model increased the area of the adhesive surface for the bacterial biofilm and reduced the accessibility of an antiseptic. The application of all the tested antiseptics in the case of the biofilm-colonized vascular graft, demonstrated the decrease in c.f.u. g −1 by seven orders of magnitude compared to the control group. The strongest antimicrobial effect was observed with 0.1% octenidine dihydrochloride, thus, a moderate effect was observed with 10% povidone-iodine. Therefore, the total eradication of viable S. aureus was not achieved by the tested antiseptics after a single application. Our findings have demonstrated disadvantages of PVGI treatment with single application of widely used antiseptics.
Single application of antiseptics fails to ensure the total eradication of the viable bacteria, which has colonized the graft, thus, possibly leading to further progression of an infection that might promote severe complications, such as systemic bacteremia, loss of limbs or even death.
Bacterial biofilms have a profound effect on health care and they are associated with 65% of all the infections [20, 21] . In order to prove the effectiveness of a disinfectant against the bacteria, the disinfectant should cause a 5 log (99.999%) decrease after its contact with the bacteria [22] . A biofilm is a complex structure, which consists of bacteria and polysaccharide matrix, both irreversibly attached to each other and some surfaces, which in clinical cases often happens to be an implant such as a vascular graft [15, [23] [24] [25] . The biofilms act as separate organisms and thus have some survival strategies, such as inhibiting the penetration of the host antibodies and lowering the growth rates of bacteria to make them unresponsive to antibiotics [26] . S. aureus in a biofilm can be up to Fig. 4 . SEM photographs of a non-impregnated woven vascular graft (Dacron) with and without S. aureus biofilm. 1000 times more resistant to antibiotics than in its planktonic form [18, 27] .
Several conservative PVGI treatment options are being studied worldwide and show satisfactory results. One of the conservative treatment options is irrigating the wound with a vascular graft with antiseptic solutions. For the in vitro experiments, we chose widely used antiseptics and tested their efficacy on integrity and viability of S. aureus biofilms, formed under different conditions, as S. aureus is one of the most common causative micro-organism, responsible for the majority of acute PVGIs [7, [28] [29] [30] . The treatment of PVGI and successful recovery is mainly complicated by severe comorbidities of the patients and partially by the structural features of the prosthetic vascular graft itself. According to Chen and Wen [31] , proper treatment of infections associated with biofilm formation must include agents, which are efficacious against micro-organisms protected by the biofilm.
In our newly developed model of PVGI in vitro, successful colonization of the vascular grafts by S. aureus biofilms was visualized by SEM. The biofilm structures on the vascular grafts resembled the structures formed on other types of infected medical devices, which were removed from the patients [32] .
Our study demonstrates limited practical application of routinely used antiseptics for management of prosthetic vascular graft infections. Strong biofilm-disrupting activity was observed when 0.02% chlorhexidine digluconate was used against S. aureus biofilms, formed on the glass coverslips in a blood-free media. This interesting finding could be explained by the lack of organic material (blood and pus), which would be able to quench the activity of chlorhexidine digluconate or other chlorine-based antiseptics [33, 34] and the fact that the glass coverslips have no organic material, but with the same exposure time, the efficacy is worse than the models with organic material (PVGI and LCWPB). Previous studies emphasize advantages (broad spectrum bactericidal activity, low irritation, affordability) of chlorhexidine, hence, they also underline its sensitivity to pH [33, 34] . Lower biofilmdisrupting efficacy of 0.1% octenidine dihydrochloride and 10% povidone-iodine could be explained by a relatively short exposure time and the lack of combinational treatment strategies, as Johani et al. [35] observed in their research.
In order to simulate biofilm structures better, as seen in vivo and to evaluate the antimicrobial effect of antiseptics in blood-based media, the LCWPB model was modified and successfully used. We found that under protein-rich conditions, 0.02% chlorhexidine digluconate had demonstrated limited antimicrobial activity, compared to 0.1% octenidine dihydrochloride and 10% povidone-iodine. This finding supports the hypothesis of inhibitory effect of protein-rich environment, related to the antimicrobial activity of chlorhexidine [33, 34] .
The differences among the efficacy of the tested antimicrobials, concerning the viability of S. aureus biofilms, formed in blood-rich media, could be first explained by the differences of the chemical stability of particular antiseptics, as well as by possibly different mechanisms of antimicrobial activity. Our findings are supported by Amalaradjou et al.'s study, which was focused on the antimicrobial activity of octenidine hydrochloride against biofilms, formed by highly Methicillin-resistant S. aureus and Vancomycin-resistant S. aureus strains. The study revealed a strong antimicrobial effect of this antiseptic and its efficacy was not affected by proteinrich conditions, such as the presence of blood serum [36] .
Our study confirms that octenidine dihydrochloride can maintain antimicrobial activity against S. aureus biofilms even under the presence of blood proteins as no viable bacteria were found in the LCWPB model after application of these two antimicrobials. These findings coincide with other studies, suggesting an effective antimicrobial efficacy against S. aureus biofilms using undiluted povidone-iodine [36, 37] . The major disadvantage of using povidone-iodine is its strong cytotoxic effect. The profound cytotoxicity of povidone-iodine to osteoblasts, fibroblasts and myoblasts in vitro, which could impair further recovery and might be one of the major causes of the implant's rejection, has been documented by Liu et al.'s study [38] .
Our study has several limitations. First, in vitro conditions cannot accurately represent a clinical situation and there is a need for in vivo verification of our results. Second, the most important limitation of the biofilm formation is that there is no standard method to assess the susceptibility of the disinfectant. Bacterial strains, disinfectants and their concentrations, duration of the application and neutralizer solutions must be standardized to compare our results with other studies.
In conclusion, we implemented an innovative in vitro model on S. aureus biofilms grown in different settings, including a clinically challenging situation of PVGI. This model allowed us to evaluate the efficacy of three popular antiseptic solutions. All the tested antiseptics had certain biofilm-disrupting activity on S. aureus biofilms (on glass coverslips) and antibacterial effect in the modified LCWPB model, however, all of them failed to fully eradicate the bacteria from the infected vascular graft by a single application. The strongest antimicrobial activity against S. aureus biofilms, grown on prosthetic vascular grafts, was showed by 0.1% octenidine dihydrochloride. Considering the chemical instability of 0.02% chlorhexidine digluconate and profound cytotoxicity of 10% povidone-iodine, 0.1% octenidine dihydrochloride makes a good candidate for the treatment of PVGI. Since our experiments revealed chlorhexidine's outstanding biofilm-disruptive properties and great antibacterial effect of both povidone-iodine and octenidine dihydrochloride, we suggest that combinational therapy of antiseptics between chlorhexidine with either povidone-iodine or octenidine dihydrochloride should be tested in further experiments. This might reveal biofilm-disrupting and antimicrobial properties of both antiseptics and could possibly improve the overall effect. Despite the need for further studies, our findings of these in vitro experiments will assist the management of vascular graft infection in clinical cases.
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